{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-076936","form_type":"8-K","ticker":"FENC","cik":"0001211583","company_name":"FENNEC PHARMACEUTICALS INC.","filed_at":"2024-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.367413+00:00","generated_at":"2026-05-31T23:42:41.111173+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Fennec COO Adrian Haigh departs; 66,667 options accelerated at $8.03","bullets":["Adrian Haigh left COO role effective June 30, 2024; joined as COO Aug 2023 after nine years as independent director.","Separation agreement accelerates vesting of options for 66,667 common shares at $8.03, expiring June 30, 2027.","Company actively searching for a U.S.-based leader to replace Haigh.","Haigh cited timing after Norgine licensing deal and U.S. commercial strategy refocus as reasons to step down."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-076936","json":"https://secwatch.observer/filing/0001104659-24-076936.json","markdown":"https://secwatch.observer/filing/0001104659-24-076936.md","text":"https://secwatch.observer/filing/0001104659-24-076936.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1211583/000110465924076936/0001104659-24-076936-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1211583/000110465924076936/tm2418676d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:42:41.111173+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8513616bf3","claim":"Adrian Haigh departed as Chief Operating Officer at FENNEC PHARMACEUTICALS INC..","evidence_excerpt":"On June 30, 2024, Adrian Haigh departed from his position as Fennec Pharmaceuticals Inc.’s (the \"Company\") Chief Operating Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1211583/000110465924076936/0001104659-24-076936-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}